Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/6701353.pdf
Reference22 articles.
1. Lippa EA, Carlson LE, Ehinger B, Eriksson LO, Finnstrom K, Holmin C et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992; 110: 495.
2. Lippa EA, Schuman JS, Higginbotham EJ, Kass MA, Weinrib RN, Skuta GL et al. MK-507 versus sezolamide: a comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology 1991; 98(3): 308.
3. Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993; 111: 1343.
4. Kitazawa Y, Azuma I, Iwata K, Tsukahara S, Shioes Y, Araie M et al. Dorzolamide, a topical carbonic anhydrase inhibitor: a two-week dose response study in patients with glaucoma or ocular hypertension. J Glaucoma 1994; 3: 275–279.
5. Strahlman E, Tipping R, Vogel R, the International Dorzolamide Study Group. A double masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol 1995; 113: 1009–1016.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS;Retina;2022-11
2. Carbonic Anhydrase Inhibitors in Ophthalmology: Glaucoma and Macular Oedema;Progress in Drug Research;2021
3. Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos- Related Macular Cystoid Lesions: A Case Series;Turkish Journal of Ophthalmology;2020-01-01
4. Prescribing Trends of Topical Glaucoma Medications in Australia From 2001 to 2017;Journal of Glaucoma;2019-11-26
5. Medical Treatment: First-Line Agents, Monotherapy, and Combination Therapy;Pearls of Glaucoma Management;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3